Key result
Iatrogenic cardiac tamponade during electrophysiology procedures did not significantly increase long-term mortality or major cardiovascular events (HR 1.22) compared to matched controls.
Why the study?
The long-term association of iatrogenic cardiac tamponade complicating invasive electrophysiology procedures with mortality and serious cardiovascular events was not established in nationwide cohorts.
Does iatrogenic cardiac tamponade increase the risk of mortality or serious cardiovascular events in patients undergoing invasive electrophysiology procedures?
Cohort (n=600)
Yes
Does iatrogenic cardiac tamponade increase the risk of mortality or serious cardiovascular events in patients undergoing invasive electrophysiology procedures?
Iatrogenic cardiac tamponade during electrophysiology procedures does not appear to increase long-term mortality or major cardiovascular events, though it strongly increases short-term hospitalizations for pericarditis.
AIMS: To investigate the association of iatrogenic cardiac tamponades as a complication of invasive electrophysiology procedures (EPs) and mortality as well as serious cardiovascular events in a nationwide patient cohort during long-term follow-up. METHODS: From the Swedish Catheter Ablation Registry between 2005 and 2019, a total of 58 770 invasive EPs in 44 497 patients were analysed. From this, all patients with periprocedural cardiac tamponades related to invasive EPs were identified (n = 200; tamponade group) and matched (1:2 ratio) to a control group (n = 400). Over a follow-up of 5 years, the composite primary endpoint-death from any cause, acute myocardial infarction, transitory ischaemic attack (TIA)/stroke, and hospitalization for heart failure-revealed no statistically significant association with cardiac tamponade [hazard ratio (HR) 1.22 (95% CI, 0.79-1.88)]. All single components of the primary endpoint as well as cardiovascular death revealed no statistically significant association with cardiac tamponade. Cardiac tamponade was associated with a significantly higher risk with hospitalization for pericarditis [HR 20.67 (95% CI, 6.32-67.60)]. CONCLUSION: In this nationwide cohort of patients undergoing invasive EPs, iatrogenic cardiac tamponade was associated with an increased risk of hospitalization for pericarditis during the first months after the index procedure. In the long-term, however, cardiac tamponade revealed no significant association with mortality or other serious cardiovascular events.
No takes yet. Share an insight, caveat, or question.
Olshausen et al. (2023) conducted a cohort in Patients undergoing invasive electrophysiology procedures (n=600). Periprocedural cardiac tamponade requiring pericardiocentesis vs. No periprocedural cardiac tamponade was evaluated on Composite of death from any cause, acute myocardial infarction, TIA/stroke, and hospitalization for heart failure (HR 1.22, 95% CI 0.79-1.88, p=0.382). Iatrogenic cardiac tamponade during electrophysiology procedures did not significantly increase long-term mortality or major cardiovascular events (HR 1.22) compared to matched controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: